Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 28

Sort by

Sort Order Select

Journal Articles

Reduced Relapse Risk in Children with Acute Myeloid Leukemia (AML) Who Experience Septic Shock (SS)

Alix E. Seif, MD, Yimei Li, PhD, Viviane C. Cahen, Yuan-Shung V. Huang, MS, Matt Hall, PhD, E. Anders Kolb, MD, Brian T. Fisher, DO, MSCE, Richard Aplenc, MD PhD, Kelly D Getz

Blood (2019) 134 (Supplement_1): 3496.

https://doi.org/10.1182/blood-2019-122887

Published: 2019

Journal Articles

Area-Based Socioeconomic Disparities in Survival of Children with Newly Diagnosed Acute Myeloid Leukemia: A Report from the Children's Oncology Group

Lena E. Winestone, MD, Kelly D Getz, Kira O Bona, MDMPH, Brian T. Fisher, DO, MSCE, Alan S Gamis, MD MPH, Alix E. Seif, MD, Lillian Sung, MD PhD, Yi-Cheng Wang, Todd A. Alonzo, PhD, Richard Aplenc, MD PhD

Blood (2019) 134 (Supplement_1): 703.

https://doi.org/10.1182/blood-2019-130978

Published: 2019

Journal Articles

Clinical Outcomes in Pediatric Mixed Phenotype Acute Leukemia (MPAL) Differ Depending on Disease Classification Criteria; A Multi-Center Cohort Study

Matthew J. Oberley, MD PhD, Gerald Wertheim, MD, PhD, Sunil S. Raikar, MD, Jemily Malvar, Richard Sposto, PhD, Jyotinder N. Punia, MD, Karen R. Rabin, MD PhD, Alix E. Seif, MD, Reuven J. Schore, MD, Dragos C. Luca, MD, Terri Guinipero, MD, William G. Woods, MD, Maurice R.G. O'Gorman, MD PhD, Etan Orgel, MD MS

Blood (2018) 132 (Supplement 1): 4080.

https://doi.org/10.1182/blood-2018-99-117377

Published: 2018

Journal Articles

A Novel Approach to Identifying Septic Shock (SS) in Children with Acute Lymphoblastic Leukemia (ALL) Using Pediatric Health Information System (PHIS) Data: Methods Validation and Incidence Estimation in a National Cohort

Viviane C. Cahen, Yimei Li, PhD, Evanette Burrows, MPH, Caitlin W Elgarten, MD, Amanda M. DiNofia, MD, Jennifer J. Wilkes, MD, Lena E. Winestone, MD, Yuan-Shung V. Huang, MS, Julie C Fitzgerald, MD, M. Monica Gramatges, MD PhD, Karen R. Rabin, MD PhD, Brian T. Fisher, DO, Kelly D Getz, PhD, Richard Aplenc, MD PhD, Alix E. Seif, MD

Blood (2018) 132 (Supplement 1): 3597.

https://doi.org/10.1182/blood-2018-99-114235

Published: 2018

Journal Articles

Minimal Residual Disease Risk-Stratification in Pediatric Mixed Phenotype Acute Leukemia: Results of a Multi-Center Cohort Study

Matthew J. Oberley, MD PhD, Sunil S. Raikar, MD, Jemily Malvar, Gerald Wertheim, MD, PhD, Alix E. Seif, MD, Terri Guinipero, MD, Richard Sposto, PhD, Karen R. Rabin, MD PhD, Jyotinder N. Punia, MD, Reuven J. Schore, MD, Dragos C. Luca, MD, William G. Woods, MD, Maurice R.G. O'Gorman, MD PhD, Etan Orgel, MD MS

Blood (2018) 132 (Supplement 1): 558.

https://doi.org/10.1182/blood-2018-99-113606

Published: 2018

Journal Articles

Checkpoint Inhibitors Augment CD19-Directed Chimeric Antigen Receptor (CAR) T Cell Therapy in Relapsed B-Cell Acute Lymphoblastic Leukemia

Amanda M. Li, MD, George E Hucks, Amanda M. Dinofia, MD, Alix E. Seif, MD, David T Teachey, MD, Diane Baniewicz, Colleen Callahan, Christina Fasano, Beth McBride, Vanessa Gonzalez, Farzana Nazimuddin, MS, David L. Porter, MD, Simon F Lacey, PhD BS, Carl H June, MD, Stephan A. Grupp, MD PhD, Shannon L. Maude, MD PhD

Blood (2018) 132 (Supplement 1): 556.

https://doi.org/10.1182/blood-2018-99-112572

Published: 2018

Journal Articles

Using Administrative Data to Identify Relapse and Hematopoietic Stem Cell Transplantation (HSCT) in Children with Acute Lymphoblastic Leukemia (ALL): Validation at Two Centers and Incidence Estimation in a National Cohort

Viviane C. Cahen, Yimei Li, PhD, Caitlin W Elgarten, MD, Amanda M. DiNofia, MD, Jennifer J. Wilkes, MD, Lena E. Winestone, MD, Yuan-Shung V. Huang, MS, M. Monica Gramatges, MD PhD, Karen R. Rabin, MD PhD, Brian T. Fisher, DO, Kelly D Getz, PhD, Richard Aplenc, MD PhD, Alix E. Seif, MD

Blood (2018) 132 (Supplement 1): 624.

https://doi.org/10.1182/blood-2018-99-114228

Published: 2018

Journal Articles

Increased Disease Burden Among Black Children Compared to White Children with Newly Diagnosed Acute Myeloid Leukemia

Lena E. Winestone, MD MSHP, Kelly D Getz, PhD, Yimei Li, PhD, Evanette Burrows, MPH, Michael Scheurer, MPH, PhD, M. Monica Gramatges, MD PhD, Jennifer J. Wilkes, MD, Tamara P. Miller, MDMSc, Alix E. Seif, MD, Robert W. Grundmeier, MD, Karen R. Rabin, MD PhD, Brian T. Fisher, DO, Richard Aplenc, MD PhD

Blood (2018) 132 (Supplement 1): 369.

https://doi.org/10.1182/blood-2018-99-120076

Published: 2018

Journal Articles

Severe Sepsis As Immune Stimulation and Protection from Relapse of Childhood Acute Lymphoblastic Leukemia (ALL): Results from a Pilot Study and Validation of Events in a National Administrative Dataset

Alix E. Seif, MD, Viviane C. Cahen, Yimei Li, PhD, Caitlin Walfoort Elgarten, MD, Amanda M. Dinofia, MD, Jennifer J. Wilkes, MD, Lena Winestone, MD, Yuan-Shung V. Huang, MS, Julie C Fitzgerald, MD, Brian T Fisher, DO, Gregor S. D. Reid, PhD, Kelly D Getz, Richard Aplenc, MD

Blood (2017) 130 (Supplement 1): 3445.

https://doi.org/10.1182/blood.V130.Suppl_1.3445.3445

Published: 2017

Journal Articles

Recession Increases Need for Intensive Care in Pediatric Hematologic Malignancy Presentation

Lena E. Winestone, MD, Kelly D Getz, Yimei Li, PhD, Rebecca Citrin, MD, Yuan-Shung V. Huang, MS, Kira Bona, MD MPH, Emily DePaul, MPH, Alix E. Seif, MD, Julie C Fitzgerald, MD, Brian T Fisher, DO, Richard Aplenc, MD

Blood (2017) 130 (Supplement 1): 612.

https://doi.org/10.1182/blood.V130.Suppl_1.612.612

Published: 2017

Journal Articles

Using Electronic Medical Record Data and Block Group Level Estimates of Poverty to Investigate the Association between Socioeconomic Status and Bloodstream Infection Among Pediatric Patients with Acute Leukemia

Lanair Amaad Lett, BA, MS, Kelly D Getz, Evanette Burrows, BS, Tyler Galvelis, Joseph P. Horowitz, Lena E. Winestone, MD, Alix E. Seif, MD, Brian T Fisher, DO, Richard Aplenc, MD

Blood (2017) 130 (Supplement 1): 531.

https://doi.org/10.1182/blood.V130.Suppl_1.531.531

Published: 2017

Journal Articles

Racial Disparities in Pediatric Acute Myeloid Leukemia during Induction

Lena E. Winestone, MD, Kelly Diringer Getz, PhD, Tamara P. Miller, MD, Jennifer J. Wilkes, MD, Leah Sack, Yimei Li, PhD, Yuan-Shung Huang, Alix E. Seif, MD MPH, Rochelle Bagatell, MD, Brian T. Fisher, DO, MSCE, Andrew Epstein, PhD MPP, Richard Aplenc, MD PhD

Blood (2015) 126 (23): 530.

https://doi.org/10.1182/blood.V126.23.530.530

Published: 2015

Journal Articles

Epitope Spreading Is Required for Long-Term Protection Against Acute Lymphoblastic Leukemia

Alix E. Seif, MD MPH, Sumin Jo, BSc, Jennie Altman, BSc, Hamid Bassiri, MD PhD, David M. Barrett, MDPhD, Stephan A. Grupp, MD PhD, Gregor SD Reid, PhD

Blood (2014) 124 (21): 3717.

https://doi.org/10.1182/blood.V124.21.3717.3717

Published: 2014

Journal Articles

Comparison of Resource Utilization in Children Discharged Versus Children That Remain Hospitalized Following Chemotherapy for Acute Myeloid Leukemia

Kelly D Getz, PhD, Tamara P. Miller, MD, Alix E. Seif, MD MPH, Yimei Li, PhD, Yuan-Shung Huang, MS, Rochelle Bagatell, MD, Brian T. Fisher, DO, MSCE, Richard Aplenc, MD PhD

Blood (2014) 124 (21): 3697.

https://doi.org/10.1182/blood.V124.21.3697.3697

Published: 2014

Journal Articles

Patient Factors Associated with Enrollment on an Acute Myeloid Leukemia Phase III Clinical Trial: A Report from the Children’s Oncology Group

Pooja Rao, MD, Yimei Li, PhD, Todd A. Alonzo, PhD, Lillian Sung, MD PhD, Robert B. Gerbing, MA, Kelly D Getz, PhD, Alix E. Seif, MD MPH, Tamara P. Miller, MD, Yuan-Shung Huang, MS, Rochelle Bagatell, MD, Matthew Hall, PhD, Brian T. Fisher, DO, MSCE, Alan S. Gamis, MD MPH, Richard Aplenc, MD PhD

Blood (2014) 124 (21): 2286.

https://doi.org/10.1182/blood.V124.21.2286.2286

Published: 2014

Journal Articles

Resource Utilization and Cost Analysis By Treatment Arm on the Children’s Oncology Group AALL0232 Phase 3 High-Risk B-Precursor Acute Lymphoblastic Leukemia Trial: A Report from the Children’s Oncology Group

Amanda M. DiNofia, MD, Alix E. Seif, MD MPH, Meenakshi Devidas, PhD, Yimei Li, PhD, Matthew Hall, PhD, Yuan-Shung Vera Huang, MS, Rochelle Bagatell, MD, William L. Carroll, MD, Naomi J. Winick, MD, Stephen P. Hunger, MD, Brian T. Fisher, DO, MSCE, Eric C. Larsen, MD, Richard Aplenc, MD PhD

Blood (2014) 124 (21): 210.

https://doi.org/10.1182/blood.V124.21.210.210

Published: 2014

Journal Articles

Pediatric Hospital Volume and Induction Mortality in Pediatric Acute Lymphoblastic Leukemia (ALL)

Jennifer J. Wilkes, MD, Sean Hennessy, PharmD PhD, Rui Xiao, PhD, Susan R. Rheingold, MD, Alix E. Seif, MD MPH, Yuan-Shung Huang, MS, Neika Vendetti, MPH, Yimei Li, PhD, Rochelle Bagatell, MD, Richard Aplenc, MD PhD, Brian T. Fisher, DO, MSCE

Blood (2014) 124 (21): 2653.

https://doi.org/10.1182/blood.V124.21.2653.2653

Published: 2014

Journal Articles

Treatment Toxicity and Supportive Care Utilization in Children with Down Syndrome and Acute Lymphoid Leukemia at Free-Standing Pediatric Hospitals in the United States

Elizabeth K Goodman, AB, Yimei Li, PhD, Alix E. Seif, MD MPH, Julie Fitzgerald, MD PhD, Yuan-Shung Huang, MS, Rochelle Bagatell, MD, Brian T. Fisher, DO, MSCE, Richard Aplenc, MD PhD

Blood (2014) 124 (21): 553.

https://doi.org/10.1182/blood.V124.21.553.553

Published: 2014

Journal Articles

Avascular Necrosis(AVN) and Surgical Intervention In Pediatric Acute Lymphoblastic Leukemia(ALL): A Retrospective Cohort Analysis From The Pediatric Health Information Systems (PHIS)

Mallorie B Heneghan, Susan R. Rheingold, Yimei Li, Alix E. Seif, MD, MPH, Yuan-Shung Huang, MS, Brian T. Fisher, DO, MSCE, Richard Aplenc, MD, PhD

Blood (2013) 122 (21): 1689.

https://doi.org/10.1182/blood.V122.21.1689.1689

Published: 2013

Journal Articles

Targeting mTOR Signaling Leads To Complete and Durable Responses In Children With Multi-Lineage Autoimmune Cytopenias, Including ALPS, SLE, Evans and CVID

David T. Teachey, MD, TIffaney Vincent, Kim Smith-Whitley, MD, Michele P Lambert, MD, Alix E. Seif, MD, MPH, James T. Casper, MD, Stephan A Grupp, MD, PhD

Blood (2013) 122 (21): 330.

https://doi.org/10.1182/blood.V122.21.330.330

Published: 2013

NARROW

Reduced Relapse Risk in Children with Acute Myeloid Leukemia (AML) Who Experience Septic Shock (SS)

Area-Based Socioeconomic Disparities in Survival of Children with Newly Diagnosed Acute Myeloid Leukemia: A Report from the Children's Oncology Group

Clinical Outcomes in Pediatric Mixed Phenotype Acute Leukemia (MPAL) Differ Depending on Disease Classification Criteria; A Multi-Center Cohort Study

A Novel Approach to Identifying Septic Shock (SS) in Children with Acute Lymphoblastic Leukemia (ALL) Using Pediatric Health Information System (PHIS) Data: Methods Validation and Incidence Estimation in a National Cohort

Minimal Residual Disease Risk-Stratification in Pediatric Mixed Phenotype Acute Leukemia: Results of a Multi-Center Cohort Study

Checkpoint Inhibitors Augment CD19-Directed Chimeric Antigen Receptor (CAR) T Cell Therapy in Relapsed B-Cell Acute Lymphoblastic Leukemia

Using Administrative Data to Identify Relapse and Hematopoietic Stem Cell Transplantation (HSCT) in Children with Acute Lymphoblastic Leukemia (ALL): Validation at Two Centers and Incidence Estimation in a National Cohort

Increased Disease Burden Among Black Children Compared to White Children with Newly Diagnosed Acute Myeloid Leukemia

Severe Sepsis As Immune Stimulation and Protection from Relapse of Childhood Acute Lymphoblastic Leukemia (ALL): Results from a Pilot Study and Validation of Events in a National Administrative Dataset

Recession Increases Need for Intensive Care in Pediatric Hematologic Malignancy Presentation

Using Electronic Medical Record Data and Block Group Level Estimates of Poverty to Investigate the Association between Socioeconomic Status and Bloodstream Infection Among Pediatric Patients with Acute Leukemia

Racial Disparities in Pediatric Acute Myeloid Leukemia during Induction

Epitope Spreading Is Required for Long-Term Protection Against Acute Lymphoblastic Leukemia

Comparison of Resource Utilization in Children Discharged Versus Children That Remain Hospitalized Following Chemotherapy for Acute Myeloid Leukemia

Patient Factors Associated with Enrollment on an Acute Myeloid Leukemia Phase III Clinical Trial: A Report from the Children’s Oncology Group

Resource Utilization and Cost Analysis By Treatment Arm on the Children’s Oncology Group AALL0232 Phase 3 High-Risk B-Precursor Acute Lymphoblastic Leukemia Trial: A Report from the Children’s Oncology Group

Pediatric Hospital Volume and Induction Mortality in Pediatric Acute Lymphoblastic Leukemia (ALL)

Treatment Toxicity and Supportive Care Utilization in Children with Down Syndrome and Acute Lymphoid Leukemia at Free-Standing Pediatric Hospitals in the United States

Avascular Necrosis(AVN) and Surgical Intervention In Pediatric Acute Lymphoblastic Leukemia(ALL): A Retrospective Cohort Analysis From The Pediatric Health Information Systems (PHIS)

Targeting mTOR Signaling Leads To Complete and Durable Responses In Children With Multi-Lineage Autoimmune Cytopenias, Including ALPS, SLE, Evans and CVID

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only